Viewing Study NCT00003420



Ignite Creation Date: 2024-05-05 @ 10:00 AM
Last Modification Date: 2024-10-26 @ 9:03 AM
Study NCT ID: NCT00003420
Status: COMPLETED
Last Update Posted: 2013-12-04
First Post: 1999-11-01

Brief Title: CT Scans in Treating Patients With Stage I Testicular Cancer After Undergoing Orchiectomy
Sponsor: Medical Research Council
Organization: National Cancer Institute NCI

Study Overview

Official Title: A Study of CT Scan Frequency in Patients With Stage I Testicular Teratoma
Status: COMPLETED
Status Verified Date: 2002-12
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: RATIONALE Imaging procedures such as CT scans help the doctor in detecting cancer or the recurrence of cancer Increasing the number of times a CT scan is given may improve the ability to detect stage I testicular cancer

PURPOSE Randomized clinical trial to determine if there is a different result from two different schedules of CT scans in treating patients with stage I testicular cancer after undergoing orchiectomy
Detailed Description: OBJECTIVES

Determine whether there is a difference between two schedules of CT scan surveillance in respect to stage of disease at relapse survival the investigation determining relapse and incidence of second malignancies in patients with stage I testicular teratoma after orchidectomy

OUTLINE This is a randomized multicenter study Patients are stratified by center and presence of vascular invasion

After orchidectomy patients are randomized into two schedules arms I and II of CT scan follow up

Arm I Patients repeat chest and abdominal CT scans no later than 3 months after orchidectomy and again at 12 months to confirm that the patient is clear of disease
Arm II Patients repeat chest and abdominal CT scans at 3 6 9 12 and 24 months after orchidectomy

Patients are followed monthly for the first year after orchidectomy then every 2 months for the second year then every 3 months for the third year and then every 4-6 months thereafter

PROJECTED ACCRUAL There will be 400-900 patients accrued into this study over 3-6 years

Study Oversight

Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?:
Secondary IDs
Secondary ID Type Domain Link
ISRCTN56475197 None None None
MRC-TE08 None None None
EU-98007 None None None